Bayer, Regeneron Start Phase III Trial Of VEGF Trap-Eye - NASDAQ

Bayer, Regeneron Start Phase III Trial Of VEGF Trap-Eye - NASDAQ: "

Bayer, Regeneron Start Phase III Trial Of VEGF Trap-Eye NASDAQ ... in Australia and will also be conducted in Europe and Japan. -A second study will being later this year in the US, Canada and other countries. -Diabetic Macular Edema is a leading cause of vision loss in adults under 50 suffering from diabetes. ... Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic ...PR Newswire (press release) all 13 news articles »

"